Skip to main content
OpenTrials
Completed

NCT Number: NCT01149889

Transcranial Direct Current Stimulation to Treat Major Depressive Disorder

The investigators purpose is to offer active Transcranial Direct Current Stimulation (tDCS) in patients of the investigators previous study who received either placebo or sertraline and have not responded.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2 / Phase 3

Primary location

University of Sao Paulo

São Paulo, Brazil

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients from a previous study (ID:USP-HU-001) who:

  • received sertraline and did not respond.
  • received placebo and did not respond.

Exclusion criteria

Patients from a previous study who:

  • received active tDCS.
  • responded.

Treatment and study plan

transcranial direct current stimulation

Procedure

Transcranial direct current stimulation will be applied at 2mA, 30 minutes/day, for 10 weekdays consecutively

Primary outcomes

  1. Treatment Response

    Time frame: Week 1

    Response is defined as MADRS <=12 or less than 50% of baseline MADRS (Montgomery Asberg depression rating score).

  2. Treatment response

    Time frame: Week 2

    Response defined as above.

Sponsors and collaborators

Lead sponsor

University of Sao Paulo

Other

Registry information

Official study title

An Open-label, Crossover Study on Major Depressive Disorder Using Transcranial Direct Current Stimulation

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Jun 24, 2010
Registry last updated
Dec 6, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.